Kepos Capital LP En V Veno Medical Corp Transaction History
Kepos Capital LP
- $121 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding NVNO
# of Institutions
36Shares Held
4.05MCall Options Held
34.1KPut Options Held
2.5K-
Kingdon Capital Management, L.L.C. New York, NY859KShares$3.09 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA601KShares$2.16 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT595KShares$2.14 Million0.07% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$1.44 Million3.48% of portfolio
-
Ubs Oconnor LLC Chicago, IL296KShares$1.07 Million0.05% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $34.1M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...